JEPREFI
Live / Registered — Registered (as of 25 Jun 2024)
What this means for you
Registered since 25 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79313573
- Registration number
- 7423656
- Mark type
- Stylized text
- Filed
- 23 Apr 2021
- Published for opposition
- 09 Apr 2024
- Registered
- 25 Jun 2024
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 25 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 22 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 09 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Apr 2024 — PUBLISHED FOR OPPOSITION
- 20 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 20 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Mar 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 06 Feb 2024 — CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
- 15 Mar 2023 — FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 31 Jan 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 04 Jan 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Jan 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 13 May 2022 — REG. CANCELLED - RESTORED TO PENDENCY
- 11 May 2022 — ASSIGNED TO PETITION STAFF